This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Agency for Science, Technology and Research, National University of Singapore. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018
Title: Wen Jing Sim: Innovator in Cancer Patient Stratification
Introduction
Wen Jing Sim is a notable inventor based in Singapore, recognized for her contributions to cancer research and patient stratification. Her innovative work focuses on improving clinical outcomes for cancer patients, particularly those suffering from epithelial ovarian cancer.
Latest Patents
Wen Jing Sim holds a patent titled "Patient stratification and determining clinical outcome for cancer patients." This invention outlines a method for classifying cancer in individual patients to estimate their clinical outcomes. It also includes a technique for assessing the clinical outcomes of patients with epithelial ovarian cancer. Furthermore, the invention explores how administering an EMT reversal agent can alter the epithelial mesenchymal score, thereby increasing a patient's susceptibility to anti-cancer treatments.
Career Highlights
Throughout her career, Wen Jing Sim has worked with esteemed organizations such as the Agency for Science, Technology and Research and the National University of Singapore. Her roles in these institutions have allowed her to contribute significantly to the field of cancer research and patient care.
Collaborations
Wen Jing Sim has collaborated with notable colleagues, including Jean Paul Thiery and Kian Ngiap Chua. These partnerships have further enhanced her research and innovation in cancer treatment methodologies.
Conclusion
Wen Jing Sim's work in cancer patient stratification represents a significant advancement in the field of oncology. Her innovative methods aim to improve clinical outcomes for patients, showcasing her dedication to enhancing cancer treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile